# Liqiang Xi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/liqiang-xi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 10,041 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 57 |
| i10-index | 114 |
| Last Known Institution | National Institutes of Health |
| OpenAlex ID | https://openalex.org/A5032718078 |
| ORCID iD | 0000-0001-5033-7072 |
| Works | 365 |

## Researcher papers

- [MicroRNA expression profiles of esophageal cancer](https://scholariq.org/papers/microrna-expression-profiles-of-esophageal-cancer/)
- [Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma](https://scholariq.org/papers/pilot-trial-of-adoptive-transfer-of-chimeric-antigen-receptor-transduced-t-cells/)
- [MGMT Status as a Clinical Biomarker in Glioblastoma](https://scholariq.org/papers/mgmt-status-as-a-clinical-biomarker-in-glioblastoma/)
- [Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia](https://scholariq.org/papers/clonal-evolution-leading-to-ibrutinib-resistance-in-chronic-lymphocytic-leukemia/)
- [Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study](https://scholariq.org/papers/treatment-of-metastatic-uveal-melanoma-with-adoptive-transfer-of-tumour/)
- [EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment](https://scholariq.org/papers/ebv-positive-large-b-cell-lymphomas-in-young-patients-a-nodal-lymphoma-with/)
- [Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chlorzoxazone.](https://scholariq.org/papers/benzene-poisoning-a-risk-factor-for-hematological-malignancy-is-associated-with/)
- [The clinical spectrum of Erdheim-Chester disease: an observational cohort study](https://scholariq.org/papers/the-clinical-spectrum-of-erdheim-chester-disease-an-observational-cohort-study/)
- [Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial](https://scholariq.org/papers/molecular-profiling-and-targeted-therapy-for-advanced-thoracic-malignancies-a/)
- [Both variant and IGHV4-34–expressing hairy cell leukemia lack the BRAF V600E mutation](https://scholariq.org/papers/both-variant-and-ighv4-34-expressing-hairy-cell-leukemia-lack-the-braf-v600e/)
- [Local ablative therapy (LAT) for oligoprogressive, EGFR-mutant, non-small cell lung cancer (NSCLC) after treatment with osimertinib.](https://scholariq.org/papers/local-ablative-therapy-lat-for-oligoprogressive-egfr-mutant-non-small-cell-lung/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [National Institutes of Health](https://scholariq.org/institutions/national-institutes-of-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.